| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 34.276 | 59.490 | 50.929 | 68.134 | 76.799 | 111.819 | 124.209 | 128.518 | 119.737 | 61.334 |
| Total Income - EUR | 36.604 | 60.150 | 51.977 | 69.371 | 77.598 | 114.905 | 128.523 | 130.821 | 120.435 | 61.349 |
| Total Expenses - EUR | 34.991 | 54.329 | 51.088 | 66.320 | 76.752 | 109.588 | 125.090 | 126.714 | 115.561 | 53.407 |
| Gross Profit/Loss - EUR | 1.614 | 5.821 | 888 | 3.051 | 846 | 5.318 | 3.433 | 4.107 | 4.875 | 7.942 |
| Net Profit/Loss - EUR | 516 | 4.618 | 368 | 2.358 | 70 | 4.228 | 2.330 | 2.972 | 3.839 | 6.993 |
| Employees | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Calestech-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.216 | 9.180 | 12.527 | 17.073 | 16.126 | 13.219 | 29.170 | 45.379 | 39.568 | 29.829 |
| Current Assets | 27.795 | 39.086 | 20.490 | 47.278 | 49.352 | 129.971 | 90.879 | 74.349 | 75.373 | 76.114 |
| Inventories | 14.177 | 10.003 | 11.912 | 20.355 | 30.189 | 60.431 | 47.764 | 43.615 | 36.301 | 39.040 |
| Receivables | 6.126 | 4.215 | 4.217 | 26.110 | 14.746 | 46.727 | 37.654 | 21.432 | 10.042 | 19.203 |
| Cash | 7.492 | 24.868 | 4.362 | 813 | 4.417 | 22.813 | 5.461 | 9.302 | 29.031 | 17.871 |
| Shareholders Funds | 968 | 5.576 | 5.850 | 8.101 | 8.014 | 12.090 | 14.152 | 17.167 | 20.954 | 23.291 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 38.043 | 42.690 | 27.166 | 56.290 | 57.465 | 131.100 | 105.897 | 102.561 | 93.988 | 82.652 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8009 - 8009" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Calestech-Med Srl